TBK1: A key regulator and potential treatment target for interferon positive Sjogren's syndrome, systemic lupus erythematosus and systemic sclerosis

Research output: Contribution to journalArticleAcademicpeer-review

47 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)97-102
Number of pages6
JournalJournal of Autoimmunity
Volume91
DOIs
Publication statusPublished - 2018

Research programs

  • EMC MM-02-72-02
  • EMC MM-04-54-08-A

Cite this